SPADEL SA (SPA.BR) Fundamental Analysis & Valuation

EBR:SPA • BE0003798155

Current stock price

328 EUR
-8 (-2.38%)
Last:

This SPA.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. SPA.BR Profitability Analysis

1.1 Basic Checks

  • SPA had positive earnings in the past year.
  • SPA had a positive operating cash flow in the past year.
  • In the past 5 years SPA has always been profitable.
  • SPA had a positive operating cash flow in each of the past 5 years.
SPA.BR Yearly Net Income VS EBIT VS OCF VS FCFSPA.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

1.2 Ratios

  • SPA has a better Return On Assets (10.06%) than 92.86% of its industry peers.
  • Looking at the Return On Equity, with a value of 14.70%, SPA is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • SPA has a better Return On Invested Capital (13.03%) than 89.29% of its industry peers.
Industry RankSector Rank
ROA 10.06%
ROE 14.7%
ROIC 13.03%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SPA.BR Yearly ROA, ROE, ROICSPA.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • SPA has a Profit Margin of 12.81%. This is in the better half of the industry: SPA outperforms 78.57% of its industry peers.
  • SPA's Profit Margin has improved in the last couple of years.
  • SPA has a Operating Margin (15.45%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of SPA has grown nicely.
  • SPA has a worse Gross Margin (41.98%) than 64.29% of its industry peers.
  • In the last couple of years the Gross Margin of SPA has grown nicely.
Industry RankSector Rank
OM 15.45%
PM (TTM) 12.81%
GM 41.98%
OM growth 3Y34.5%
OM growth 5Y2.92%
PM growth 3Y47.57%
PM growth 5Y4.56%
GM growth 3Y9.33%
GM growth 5Y1.52%
SPA.BR Yearly Profit, Operating, Gross MarginsSPA.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. SPA.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SPA is creating some value.
  • SPA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SPA.BR Yearly Shares OutstandingSPA.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
SPA.BR Yearly Total Debt VS Total AssetsSPA.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 7.52 indicates that SPA is not in any danger for bankruptcy at the moment.
  • SPA's Altman-Z score of 7.52 is amongst the best of the industry. SPA outperforms 100.00% of its industry peers.
  • SPA has a debt to FCF ratio of 0.15. This is a very positive value and a sign of high solvency as it would only need 0.15 years to pay back of all of its debts.
  • SPA's Debt to FCF ratio of 0.15 is amongst the best of the industry. SPA outperforms 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that SPA is not too dependend on debt financing.
  • SPA has a better Debt to Equity ratio (0.01) than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.15
Altman-Z 7.52
ROIC/WACC1.59
WACC8.17%
SPA.BR Yearly LT Debt VS Equity VS FCFSPA.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

  • SPA has a Current Ratio of 2.02. This indicates that SPA is financially healthy and has no problem in meeting its short term obligations.
  • SPA has a Current ratio of 2.02. This is in the better half of the industry: SPA outperforms 75.00% of its industry peers.
  • SPA has a Quick Ratio of 1.80. This is a normal value and indicates that SPA is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.80, SPA belongs to the top of the industry, outperforming 96.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.8
SPA.BR Yearly Current Assets VS Current LiabilitesSPA.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SPA.BR Growth Analysis

3.1 Past

  • SPA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.77%, which is quite impressive.
  • SPA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.37% yearly.
  • SPA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.82%.
  • SPA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.43% yearly.
EPS 1Y (TTM)24.77%
EPS 3Y58.78%
EPS 5Y13.37%
EPS Q2Q%45.02%
Revenue 1Y (TTM)11.82%
Revenue growth 3Y7.59%
Revenue growth 5Y8.43%
Sales Q2Q%12.97%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SPA.BR Yearly Revenue VS EstimatesSPA.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

Find the best growth stocksShow best growing peers

1

4. SPA.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 26.60 indicates a quite expensive valuation of SPA.
  • 75.00% of the companies in the same industry are cheaper than SPA, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 26.77, SPA is valued at the same level.
Industry RankSector Rank
PE 26.6
Fwd PE N/A
SPA.BR Price Earnings VS Forward Price EarningsSPA.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SPA is valued a bit more expensive than 71.43% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, SPA is valued a bit more expensive than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 35.35
EV/EBITDA 13.92
SPA.BR Per share dataSPA.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • SPA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.99
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. SPA.BR Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.66%, SPA is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.76, SPA is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.82, SPA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.66%

5.2 History

  • The dividend of SPA has a limited annual growth rate of 1.92%.
Dividend Growth(5Y)1.92%
Div Incr Years3
Div Non Decr Years3
SPA.BR Yearly Dividends per shareSPA.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0 0 0 0 0

5.3 Sustainability

  • 25.94% of the earnings are spent on dividend by SPA. This is a low number and sustainable payout ratio.
  • SPA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP25.94%
EPS Next 2YN/A
EPS Next 3YN/A
SPA.BR Yearly Income VS Free CF VS DividendSPA.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
SPA.BR Dividend Payout.SPA.BR Dividend Payout, showing the Payout Ratio.SPA.BR Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SPA.BR Fundamentals: All Metrics, Ratios and Statistics

SPADEL SA

EBR:SPA (4/29/2026, 7:00:00 PM)

328

-8 (-2.38%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Industry Strength93.92
Industry Growth67.33
Earnings (Last)09-01
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners97.59%
Ins Owner ChangeN/A
Market Cap1.36B
Revenue(TTM)399.52M
Net Income(TTM)51.19M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.66%
Yearly Dividend2.2
Dividend Growth(5Y)1.92%
DP25.94%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 26.6
Fwd PE N/A
P/S 3.41
P/FCF 35.35
P/OCF 19.11
P/B 3.91
P/tB 5.7
EV/EBITDA 13.92
EPS(TTM)12.33
EY3.76%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)9.28
FCFY2.83%
OCF(TTM)17.17
OCFY5.23%
SpS96.27
BVpS83.93
TBVpS57.55
PEG (NY)N/A
PEG (5Y)1.99
Graham Number152.596 (-53.48%)
Profitability
Industry RankSector Rank
ROA 10.06%
ROE 14.7%
ROCE 16.33%
ROIC 13.03%
ROICexc 24.04%
ROICexgc 51.64%
OM 15.45%
PM (TTM) 12.81%
GM 41.98%
FCFM 9.64%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y34.5%
OM growth 5Y2.92%
PM growth 3Y47.57%
PM growth 5Y4.56%
GM growth 3Y9.33%
GM growth 5Y1.52%
F-Score7
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.15
Debt/EBITDA 0.04
Cap/Depr 136.09%
Cap/Sales 8.19%
Interest Coverage 99.06
Cash Conversion 83.06%
Profit Quality 75.22%
Current Ratio 2.02
Quick Ratio 1.8
Altman-Z 7.52
F-Score7
WACC8.17%
ROIC/WACC1.59
Cap/Depr(3y)113.5%
Cap/Depr(5y)101.13%
Cap/Sales(3y)7.01%
Cap/Sales(5y)6.48%
Profit Quality(3y)109.11%
Profit Quality(5y)118.19%
High Growth Momentum
Growth
EPS 1Y (TTM)24.77%
EPS 3Y58.78%
EPS 5Y13.37%
EPS Q2Q%45.02%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.82%
Revenue growth 3Y7.59%
Revenue growth 5Y8.43%
Sales Q2Q%12.97%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.59%
EBIT growth 3Y44.72%
EBIT growth 5Y11.59%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.51%
FCF growth 3Y24.3%
FCF growth 5Y6.14%
OCF growth 1Y3.96%
OCF growth 3Y25.29%
OCF growth 5Y7.82%

SPADEL SA / SPA.BR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SPADEL SA (SPA.BR) stock?

ChartMill assigns a fundamental rating of 6 / 10 to SPA.BR.


What is the valuation status of SPADEL SA (SPA.BR) stock?

ChartMill assigns a valuation rating of 1 / 10 to SPADEL SA (SPA.BR). This can be considered as Overvalued.


What is the profitability of SPA stock?

SPADEL SA (SPA.BR) has a profitability rating of 7 / 10.


What is the financial health of SPADEL SA (SPA.BR) stock?

The financial health rating of SPADEL SA (SPA.BR) is 8 / 10.